Transparency
Market Research Report Added "Immunoprotein
Diagnostic Testing Market"
to its database.
Expensive
Radioimmunoassay to Trail Other Assay Market Segments
Based
on technology, chemiluminescence assay is a rapidly growing segment
and growth of this market can be attributed to a wide scope of
application, increased sensitivity, and ease of use. Fuelled by the
development of multiple ELISA technologies, the ELISA market is
expected to grow in a significant manner. On the contrary, the
radioimmunoassay segment is expected to lose its footing in the
market due to government restrictions on the use of radioactive
substances and high cost of assay equipment and safety devices. In
addition, the segment will experience a downfall as better and safer
technologies such as chemiluminescence assay, ELISA, and
immunofluorescence assay will replace radioimmunoassay soon.
Immunofluorescence and immunoturbidity assay segments are expected to
grow at a modest CAGR of about 5% during the forecast period.
The
application of immunoprotein diagnostic testing can be found in
infectious diseases, oncology testing, endocrine testing, toxicology
testing, allergy testing, and autoimmune disease testing. Oncology
testing is projected to account for a large market share in the
forecast period. Commoditization of products, growing demand for
quick, accurate, and preventive healthcare, especially in emerging
economies, technological developments, expansions in the field of
immunochromatography, and strengthening network of distributors at a
global level will contribute to the market growth – generating
maximum revenue of US$4,943.0 mn by 2019.
Browse
Market Research
Report:
http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html
http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html
High
Prevalence of Chronic Diseases to Push Sales in the U.S.
The
immunoprotein diagnostic testing market is geographically segmented
into North America, Europe, Asia Pacific, and Rest of the World. High
incidence of chronic and infectious diseases, shift to POC rapid
diagnostic tests, laboratory automation, and increased FDA approval
for new products are some of the key factors that have led North
America to dominate the said market. According to the report, this
region is projected to continue enjoying its top position in the
forecast period as well.
Developing
economies of Asia Pacific are also expected to contribute to the
market growth in the years to come. Better healthcare facilities,
increase in disposable income, improving literacy rate, and growing
awareness about major infectious and chronic diseases are few of the
factors that are fuelling the demand for immunoprotein diagnostic
testing in this region.
Fill
the form for an exclusive sample of this report:
No comments:
Post a Comment